REVOLADE , thrombopoietin receptor agonist

website revolade Revolade is indicated in adult patients with chronic hepatitis C virus infection for the treatment of thrombocytopenia, where the degree of revolade Revolade pCPA File Number: 20760 Negotiation Status: Negotiations were not pursued Indication: Thrombocytopenia associated

revolade Revolade 50 Tablet is used to prevent or lower the risk of bleeding in patients with chronic immune thrombocytopenic purpura   SmPC updated with details of new paediatric indication: “Revolade is indicated for chronic immune thrombocytopenic purpura patients aged 1  Revolade is a once-daily oral thrombopoietin receptor agonist that works by inducing stimulation and differentiation of megakaryocytes (

Share

Share

Link

Turn off sharing Copy link

See all details